Insider Trading Alert - WBMD, OSIS And KOS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 9, 2014, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $46.83 to $226,304,343.30.

Highlighted Stocks Traded by Insiders:

WebMD Health (WBMD) - FREE Research Report

Manning James V, who is Director at WebMD Health, sold 6,979 shares at $48.00 on Sept. 9, 2014. Following this transaction, the Director owned 125,269 shares meaning that the stake was reduced by 5.28% with the 6,979-share transaction.

The shares most recently traded at $47.70, down $0.30, or 0.63% since the insider transaction. Historical insider transactions for WebMD Health go as follows:

  • 4-Week # shares sold: 118,192
  • 12-Week # shares sold: 221,431
  • 24-Week # shares sold: 221,431

The average volume for WebMD Health has been 567,700 shares per day over the past 30 days. WebMD Health has a market cap of $1.9 billion and is part of the technology sector and computer software & services industry. Shares are up 20.08% year-to-date as of the close of trading on Tuesday.

WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. The company has a P/E ratio of 71.6. Currently, there are 4 analysts who rate WebMD Health a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBMD - FREE

TheStreet Quant Ratings rates WebMD Health as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full WebMD Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Private Briefing: KKR's Healthcare Deal Spree

KKR's WebMD Acquisition Is a Big Win for an Activist Investor